Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma - Van Tine, Brian A.; Ingham, Matthew A.; Attia, Steven; Meyer, Christian F.; Baird, John D.; Brooks-Asplund, Esther; D'Silva, Dhiren; Kong, Ronald; Mwatha, Anthony; O'Keefe, Kylie; Weetall, Marla; Spiegel, Robert; et al. (Journal of clinical oncology, 2024)
Keywords: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Dacarbazine - administration & dosage; Dacarbazine - adverse effects; Female; Humans; Leiomyosarcoma - drug therapy; Leiomyosarcoma - pathology; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local - drug therapy; Neoplasm Recurrence, Local - pathology; Original Reports